Methadone for Pain Management in Children with Cancer

被引：19

作者：

Habashy, Catherine ^{[1
]}

Springer, Erin ^{[2
]}

Hall, Elizabeth A. ^{[3
]}

Anghelescu, Doralina L. ^{[4
]}

机构：

[1] Childrens Natl Med Ctr, Dept Pediat, Div Hospitalist Med, Washington, DC 20010 USA

[2] Johns Hopkins Univ Hosp, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21287 USA

[3] St Jude Childrens Res Hosp, Pharmaceut Serv, 332 N Lauderdale St, Memphis, TN 38105 USA

[4] St Jude Childrens Res Hosp, Dept Pediat Med, Div Anesthesia, 332 N Lauderdale St, Memphis, TN 38105 USA

来源：

PEDIATRIC DRUGS | 2018年 / 20卷 / 05期

关键词：

ACUTE LYMPHOBLASTIC-LEUKEMIA; HIGH-DOSE METHADONE; ORAL METHADONE; DE-POINTES; MORPHINE; CELLS; PHARMACOKINETICS; ANALGESIA; APOPTOSIS; RECEPTOR;

D O I：

10.1007/s40272-018-0304-2

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Methadone is a synthetic opioid with unique pharmacodynamic and pharmacokinetic properties. It is effective in treating both nociceptive and neuropathic pain, which commonly co-exist in children with cancer. Upon reviewing the literature describing the use of methadone in pediatric oncology patients, publications are limited in number and low in quality of evidence; nevertheless, there is support for the safety and efficacy of methadone in treating pain in children with cancer, particularly when pain is refractory to conventional treatment. Although the risk of life-threatening arrhythmia is commonly cited as an argument against the use of methadone, our review of the literature did not support this finding in children. Further evaluation with prospective studies is warranted to develop evidence-based recommendations for the use of methadone in pediatric oncology.

引用

页码：409 / 416

页数：8

共 35 条

[1] Severe Central Sleep Apnea in a Child With Leukemia on Chronic Methadone Therapy [J].

Amos, Louella B. ;

D'Andrea, Lynn A. .

PEDIATRIC PULMONOLOGY, 2013, 48 (01) :85-87

[2]

Anghelescu Doralina L, 2016, J Opioid Manag, V12, P131, DOI 10.5055/jom.2016.0325

[3]

Anghelescu Doralina L, 2011, J Opioid Manag, V7, P353

[4]

Bonertz L, 2007, CAN PHARM J, V140, P298, DOI 10.3821/1913701X2007140298POMIBA20CO2

[5]

CODD EE, 1995, J PHARMACOL EXP THER, V274, P1263

[6] Methadone analgesia for children with advanced cancer [J].

Davies, Dawn ;

DeVlaming, Deborah ;

Haines, Christina .

PEDIATRIC BLOOD & CANCER, 2008, 51 (03) :393-397

[7]

Davis AM, 1999, J PHARMACOL EXP THER, V289, P1048

[8] Methadone for relief of cancer pain: a review of pharmacokinetics, pharmacodynamics, drug interactions and protocols of administration [J].

Davis, MP ;

Walsh, D .

SUPPORTIVE CARE IN CANCER, 2001, 9 (02) :73-83

[9] Methadone - metabolism, pharmacokinetics and interactions [J].

Ferrari, A ;

Coccia, CPR ;

Bertolini, A ;

Sternieri, E .

PHARMACOLOGICAL RESEARCH, 2004, 50 (06) :551-559

[10] Methadone, commonly used as maintenance medication for outpatient treatment of opioid dependence, kills leukemia cells and overcomes chemoresistance [J].

Friesen, Claudia ;

Roscher, Mareike ;

Alt, Andreas ;

Miltner, Erich .

CANCER RESEARCH, 2008, 68 (15) :6059-6064

← 1 2 3 4 →